Loading...
•
Dec 31, 2024
Pulmonx Q4 2024 Earnings Report
Pulmonx reported record fourth quarter and full year 2024 financial results, with significant revenue growth and improved net loss.
Key Takeaways
Pulmonx reported record worldwide revenue of $23.8 million for Q4 2024, a 23% increase year-over-year, and $83.8 million for the full year 2024, a 22% increase. The company also achieved a gross margin of 74% for both the quarter and the full year, and reduced its net loss compared to the previous year.
Record worldwide revenue of $23.8 million in Q4 2024, up 23% year-over-year.
Record full year 2024 worldwide revenue of $83.8 million, up 22% year-over-year.
Gross margin of 74% achieved for both Q4 and full year 2024.
Net loss improved to $13.2 million in Q4 2024 and $56.4 million for full year 2024.
Revenue by Geographic Location
Forward Guidance
Pulmonx expects full year 2025 revenue to be between $96 million and $98 million, representing 15% to 17% growth (16% to 18% on a constant currency basis), with an expected gross margin of approximately 74% and total operating expenses between $133 million and $135 million.
Positive Outlook
- Expected revenue growth of 15% to 17% for full year 2025.
- Expected constant currency revenue growth of 16% to 18% for full year 2025.
- Anticipated gross margin of approximately 74% for full year 2025.
- Continued investments in commercial activities and clinical development.
- Confidence in driving long-term, sustainable growth in 2025 and beyond.
Challenges Ahead
- Guidance assumes a negative impact from foreign exchange on reported revenue growth of approximately 100 basis points.
- Total operating expenses are expected to be between $133 million and $135 million.
- Approximately $22 million of non-cash stock-based compensation is included in operating expenses.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...